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Aim: Cardiac toxicity due to the administration of local anesthetics may be fatal. In this study, we evaluated the efficacy of a 20% lipid
solution combined with epinephrine in a levobupivacaine-induced cardiac arrest model.
Materials and methods: A total of 14 New Zealand rabbits were sedated and mechanically ventilated. Asystole was induced with
intravenous levobupivacaine injection. The rabbits were randomized into groups receiving the same volume of either 0.9% saline (CR
group) or a 20% lipid solution (LE group) along with a 100 µg/kg epinephrine bolus, which were administered immediately upon
asystole. Standard advanced cardiac life support protocols were performed.
Results: Four subjects in the LE group as well as 3 subjects in the CR group had a spontaneous recovery (P = 0.592). In the 20th minute
after arrest, 3 subjects in the LE group had maintained spontaneous circulation, while there was only 1 subject from the CR group with
the same outcome.
Conclusion: We found that adding a lipid solution to epinephrine for the resuscitation of rabbits that underwent levobupivacaineinduced cardiac arrest increased recovery rates of circulation and therefore the likelihood of survival. Further studies are needed to
develop clinical therapies for the systemic toxicity of local anesthetics.
Key words: Levobupivacaine, lipid emulsion, epinephrine, toxicity, resuscitation

1. Introduction
In cases where toxicity was caused by long-acting local
anesthetic agents, the infusion of a lipid emulsion was
shown to facilitate spontaneous circulation recovery and
to increase the rate of revival in both animals and humans
(1). Studies have shown that lipid dosing for resuscitation
varies in experimental models having toxicity due to local
anesthetics and lipophilic cardiotoxins (1). Similarly,
clinical reports in which the subjects were successfully
resuscitated from local anesthetic-induced cardiac arrest
have been reported using different doses (2–7). However,
studies testing lipid dosing have never been conducted in
animals or humans. An intravenous lipid emulsion has
been shown to be effective in the treatment of bupivacaineinduced cardiac arrest (1,8–10). Clinical trials in which a
lipid emulsion was used in resuscitating subjects with local
anesthetic-induced cardiotoxicity have had successful
results (3,4,6,7,11). In light of the efficacy in experimental
* Correspondence: muratkarcioglu@hotmail.com
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and clinical trials, lipid emulsion is now considered a
critical component of resuscitation in systemic toxicity
caused by local anesthetics (12).
Epinephrine is administered during cardiopulmonary
resuscitation because it regulates coronary and cerebral
perfusion pressures and blood flow. Although epinephrine
is used globally in resuscitation, there is insufficient
evidence of its survival benefit in humans. There are
reports of both favorable and toxic effects of epinephrine
administration in the cardiopulmonary resuscitation of
animals and humans (13).
The inappropriate use of local anesthetics in routine
procedures may have devastating effects (14). Several
case reports indicated successful resuscitation with lipids
on human subjects in cases where cardiopulmonary
resuscitation (CPR) with epinephrine and atropine failed
to treat cardiovascular collapse (2,3,6). Trials with human
volunteers and local anesthetics with potential fatal effects
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have not been approved, but lipid emulsion administration
has promise in relieving local anesthetic toxicity (14).
There are several studies investigating the effect
of Intralipid against bupivacaine-induced cardiac
arrest model, but there is a little information about
levobupivacaine-induced cardiac arrest. In the literature,
levobupivacaine is usually preferred instead of bupivacaine
due to its lower cardiac toxic effects. According to the
English-language literature, this is the first study exploring
the effect of Intralipid against levobupivacaine-induced
cardiac arrest models in rabbits.
This study aims to evaluate the effects of adding a
lipid emulsion to epinephrine-based resuscitation. We
tested the hypothesis that epinephrine-based resuscitation
in combination with a lipid emulsion may have a better
outcome in subjects with levobupivacaine-induced
asystole.
2. Materials and methods
After obtaining the consent of the Mustafa Kemal
University Ethics Committee for Animal Trials, the study
was conducted at the Experimental Animal Application
and Research Center. A total of 14 adult white New
Zealand rabbits at 110–140 days of age, including both
sexes, were included in the study. Subjects were divided
into 2 groups of 7 as follows:
Group 1: Conventional resuscitation group (CR group),
Group 2: Lipid emulsion Group (LE group).
The rabbits were sedated with 50 mg/kg ketamine and
4 mg/kg xylazine intramuscularly on the day of the trial.
After sedation, the animals were put on the operating table
and venous access was opened at the marginal ear vein.
Ketamine infusion was initiated at an hourly rate of 10
mg/kg and was maintained throughout the experiment.
Subjects were monitored by ECG at all times. Tracheostomy
was performed following a 2-mL subcutaneous lidocaine
injection. Pressure-controlled mechanical ventilation (at 15
cm of H2O inspiratory pressure) was then initiated at a rate
of 17 respirations/min using 100% oxygen (inspiratory-toexpiratory ratio = 0.5:3). End-tidal CO2 was maintained
in a range between 2% and 5%. Vecuronium, a muscle
relaxant, was administered at a dose of 0.1 mg/kg after
mechanical ventilation.
The left carotid artery, the internal jugular vein, and the
right subclavian vein were dissected and visualized. The
internal carotid artery was catheterized using a 20-gauge
cannula through the proximal aorta and continuous blood
pressure monitoring was provided. Monitoring was also
initiated with a 20-gauge catheterization from the superior
vena cava through the right atrium. Both transducers were
calibrated regarding the middle thorax and were reset
at room air. After the invasive period, the operation was
paused for stabilization (around 10 min).

2.1. Levobupivacaine arrest protocol
To achieve arrest, 10 mg/kg levobupivacaine was
administered through the ear marginal vein for 5 s.
2.2. Resuscitation protocol
Clinical response was evaluated in a 30-s period without
intervention after asystole. Basic life support, including
manual chest compression and mechanical ventilation,
was performed according to arterial blood pressure (160
compression rate and 17 respirations/min).
During the first minute, subjects were randomly
enrolled in either the LE or CE group. In the LE group,
1.5 mL/kg 20% intravenous Intralipid was administered
within 1 min via the ear vein. For subjects that failed to
have spontaneous circulation, or those that had another
cardiac arrest after spontaneous circulation, 1.5 mL/kg
intravenous Intralipid was administered in 5-min intervals
In the CR group, 1.5 mL/kg 0.9% intravenous saline
was administered within 1 min via the ear vein. In subjects
that failed to have spontaneous circulation, or those that
had another cardiac arrest after spontaneous circulation,
1.5 mL/kg 0.9% intravenous saline was administered in
5-min intervals
If the mean arterial pressure was over 50 mmHg and
the heart rate exceeded 120 bpm, this was considered as
recovery of spontaneous circulation.
After initial boluses, 100 µg/kg intravenous
epinephrine was given to both groups in 5-min intervals
until spontaneous circulation was maintained.
Chest compression was continued until spontaneous
circulation was maintained. In cases of asystole, or in
those where the mean arterial pressure decreased, chest
compression was initiated.
We continued resuscitation for 20 min, after which
all subjects were euthanized using 300 mg of intravenous
pentobarbital.
2.3. Statistical analysis
Assuming that the difference in coronary perfusion
pressure (CPP) measurements between the CR and LE
groups was 10 mmHg, the standard derivation was 11, and
if α = 0.05 and β = 0.5, the sample size was estimated to
be 7 for each group. A Mann–Whitney U test was used to
compare the estimated values, and a chi-square test was
used to compare the categorical variables.
3. Results
Table 1 summarizes the features of the subjects and their
basal hemodynamic parameters. The 2 groups were
statistically comparable with respect to heart rate (HR),
mean arterial pressure (MAP), CPP, and right atrium
pressure (RAP) prior to the procedure.
Arterial blood gas (ABG) variables recorded 20 min
before and after cardiac arrest are presented in Table 2.
ABG variables were not statistically different between the
2 groups before and after cardiac arrest.
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Table 1. Baseline animal characteristics and haemodynamic metrics. Data are mean
(SEM).
CR (n = 7)

LE (n = 7)

P-value

Sex (male:female)

4:3

4:3

1.0

Age (days)

124 (10)

121 (9)

0.522

Weight (kg)

3.45 (0.29)

3.32 (0.25)

0.274

HR (beats/min)

181 (13)

187 (14)

0.482

MAP (mmHg)

67 (8)

63 (5)

0.124

CPP (mmHg)

57 (10)

52 (4)

0.276

RAP (mmHg)

2.7 (0.9)

2.4 (0.7)

0.476

Table 2. Arterial blood gas variables at baseline. Data are mean (SEM).
CR (n = 7)

LE (n = 7)

P-value

pH

7.41 (0.06)

7.37 (0.05)

0.178

PaO2 (mmHg)

235 (51)

246 (33)

0.848

PaCO2 (mmHg)

33 (6)

33 (5)

0.652

HCO3 (mmol/L)

24 (4.1)

24 (2.8)

0.270

Base excess (mmol/L)

1.5 (4.1)

2.5 (3.4)

0.516

Lactate (mmol/L)

2.0 (1.05)

2.1 (0.55)

0.563
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Within 12 s after levobupivacaine injection, asystole
was observed in all subjects. Recovery of spontaneous
circulation (ROSC) was 6.5 ± 4.1 min in the LE group and
9.0 ± 1.5 min in the CE group (P = 0.285).
CPP values before and after cardiac arrest are shown
in Figure 1. There were significant differences in CPP
between the 2 groups at the 4th, 5th, 6th, and 7th minutes
of CPR (P = 0.045, P = 0.010, P = 0.022, and P = 0.029,
respectively).
Four subjects in the LE group and 3 subjects in the CR
group had ROSC (P = 0.592). Two of the 3 subjects in the
CR group collapsed twice and persistent cardiac arrest
occurred. One of 4 subjects in the LE group collapsed
in the 15th minute and did not respond to resuscitation.
Finally, 3 subjects in the LE group and 1 subject in the CR
group maintained ROSC for 20 min (P = 0.237).
Figure 2 shows the MAP values. There were significant
differences in MAP between the 2 groups at the 1st, 2nd,
5th, 7th, and 11th minutes of CPR (P = 0.017, P = 0.05, P =
0.007, P = 0.05, P = 0.05; respectively).
Heart rate values can be seen in Figure 3. There was no
difference between groups.

LE
CR

50
40
30
20
10
0

0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Minutes

Figure 1. Coronary perfusion pressure (CPP) vs. time during the
20 min of resuscitation. Data represent mean ± SEM. LE = Lipid
emulsion group; CR = conventional resuscitation group. *: P <
0.05.

Analysis at the 20th minute after cardiac arrest revealed
no difference between groups (Table 3).
Necropsy confirmed the appropriate positioning of the
tracheal tube and vascular catheters in all animals.
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Figure 2. Mean arterial pressure (MAP) vs. time during the 20
min of resuscitation. Data represent mean ± SEM. LE = Lipid
emulsion group; CR = conventional resuscitation group. *: P ≤
0.05; **: P < 0.01.

Figure 3. Heart rate (HR) vs. time during the 20 min of
resuscitation. Data represent mean ± SEM. LE = Lipid emulsion
group; CR = conventional resuscitation group.

Table 3. Arterial blood gas variables at 20th minute. Data are mean (SEM).
CR (n = 7)

LE (n = 7)

P-value

pH

6.99 (0.07)

6.99 (0.06)

0.563

PaO2 (mmHg)

37 (16.3)

40 (8.6)

0.520

PaCO2 (mmHg)

77 (18)

87 (9.2)

0.222

HCO3 (mmol/L)

30 (8)

28 (6.23)

0.897

Base excess (mmol/L)

–10 (1.8)

–13 (7.48)

0.333

Lactate (mmol/L)

11 (2.4)

10.5 (3.1)

0.654

4. Discussion
Our data show that adding a lipid emulsion to resuscitation
had better hemodynamic outcomes than using epinephrine
alone in a levobupivacaine overdose in rabbits. To the best
of our knowledge, this is the first study evaluating efficacy
of Intralipid against a levobupivacaine-induced cardiac
arrest model in rabbits.
Although there was no difference in metabolic
measures, several aspects of cardiac functions were better
in animals that also had lipid administration than in those
who received epinephrine alone.
The results show that epinephrine + lipid administration
is superior to epinephrine alone in the setting of
levobupivacaine-induced cardiac toxicity management.
Many clinical reports state that lipid administration
after the failure of adrenergic therapy can recover
spontaneous circulation in a short period of time (2,3).
When epinephrine was used alone to recover circulation
in local anesthesia-induced cardiac arrest, those subjects
still had life-threatening, unfavorable hemodynamic
outcomes. In contrast, subjects who underwent lipid
therapy had initially worse hemodynamic outcomes, but
gradual improvement was subsequently achieved (15).

This condition is consistent with the results of the
study conducted by Weinberg et al. In that study, the
group receiving epinephrine experienced increased blood
pressure (168/120) followed by severe hypotension (70/40)
and prolonged mechanical ventilation (16).
Previous cardiac arrest models have used blood pressure
as their primary recovery criterion (17–20). However,
Weinberg et al. observed that increased systolic pressures
during the first minutes of epinephrine administration
were not maintained, nor were they correlated with cardiac
and metabolic measures at the end of the trial (16). In this
study, some of the results from the rats in the epinephrine
group were less favorable than those in the saline group [i.e.
rate pressure product, lactate, partial pressure of oxygen in
arterial blood (PaO2)], and some of the results were much
worse [i.e. central venous oxygen saturation, pH, partial
pressure of carbon dioxide in arterial blood (PaCO2)].
In contrast, the systolic pressures of the group that was
administered a lipid emulsion were significantly lower than
those of the epinephrine group at 2.5 and 5 min, but were
significantly higher by the end of the trial (16). This model
suggests that during bupivacaine overdose, early systolic
hypertension is not a reliable indicator for recovery.
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Harvey et al. used increments of coronary perfusion
pressure as a recovery criterion (21). Similarly, Weinberg
at al. performed a study on dogs, which have larger CPP
values, and found that open chest compression increased
general survival (9). These results are consistent with the
findings of a previous rabbit study (findings of the group
without epinephrine injection) (1).
Mayr et al. created a bupivacaine-induced asphyxia
model for pigs. In that study, they reported that the
epinephrine group had higher CPP levels than the group
receiving lipids only. In addition, survival rates were higher
in the group receiving only lipids (20).
We considered systolic pressure as a recovery criterion
in our study, but we also observed that increased CPP
and its maintenance improved survival rates. Both
groups were shown to have higher CPP after epinephrine
administration. This increase was maintained in the LE
group for 10 min but, in the CR group, CPP decreased.
This also affected the number of animals that survived, as
in the LE group there were more subjects that survived.
Inadequate circulation to recover spontaneous
circulation causes not only insufficient perfusion but also
an insufficient flow effect for the clearance of toxins. In this
situation, the sink effect is not strong enough. The sink
hypothesis suggests that to decrease toxicity, lipophilic
drugs should be dissolved in an expanded plasma lipid
phase (21). In humans, CPR can be achieved if CPP is
as high as 10–20 mmHg (22), and therefore the highest
priority should be to optimize myocardial perfusion in
subjects with local anesthesia-induced cardiac arrest (9).
Harvey et al. conducted a bupivacaine-induced cardiac
arrest study on rabbits. In that study, all treatment groups
exhibited profound respiratory acidosis and hypoxia at 15
min regardless of epinephrine administration, although
they all had same prearrest adjustment (21).
In this study, both groups had profound respiratory
acidosis and hypoxia at the 20th minute. The potential
causes of death for subjects may be decreased pH, recovered
spontaneous circulation (23), ongoing hypoxia, or cardiac
depression (24). Epinephrine administration supports
spontaneous circulation under these circumstances.
Although the final outcome might have been unfavorable
in these subjects, these results still support the benefits of
epinephrine administration (21).
Intravenous lipid emulsion has been shown to cause
a profound increase in pulmonary vascular resistance in
animal models (25,26) and neonates (27,28). These effects
become worse in settings of hypoxia.
Lipid particles of larger than 5 µm may cause lipid
embolism (29), which can cause an increase in pulmonary
vascular resistance and impair pulmonary flow during
slow-paced CPR.
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All of these factors may have impaired gas exchange
in our study. We did not evaluate pulmonary vascular
pressures in this model, and so the level of impact on gas
exchange cannot be evaluated.
Numerous studies have reported that arrhythmia caused
by epinephrine in the treatment of bupivacaine-induced
toxicity is quite problematic (16). Heavner et al. found
that if epinephrine was given to rats under bupivacaineinduced asystole, ventricular extrasystoles occurred at
higher frequencies (17). Similarly, Groban et al. observed
that epinephrine caused persistent ventricular fibrillation in
more than half of the dogs that had bupivacaine overdose
(19). Similarly, Weinberg et al. found that all of the subjects
in the epinephrine group had persistent ventricular ectopy
during the experiment, while none of the subjects in this
study had ventricular ectopy. In comparison with the lipid
group, epinephrine worsened tissue perfusion, cardiac
output, and oxygen delivery (16). Moreover, epinephrine
may have a direct metabolic effect by increasing serum
lactate levels without tissue perfusion (30).
We observed ectopic beats in both groups, but we
noticed them especially in CR subjects that had recovered
spontaneous circulation, recurrent collapse, persistent
ventricular arrhythmia, and fibrillations after epinephrine
administration. These subjects could not survive, and in
the LE group, severe arrhythmias, with the exception of
ventricular ectopic beat, were not observed.
Reinikainen et al. reported that prolonged pulmonary
edema occurred after epinephrine administration in
patients with local anesthetic-induced cardiac arrest (31).
Pulmonary edema causes hypoventilation and subsequent
hypercapnia, both of which facilitate acidosis. We observed
hypercapnia and prolonged acidosis in both groups, but
we think that the pulmonary edema findings were subtle.
Different criteria for ROSC may cause variable
outcomes. Mayr et al. (20) uses the criterion of systolic
pressure over 80 mmHg for at least 5 min. Weinberg et
al. used their own criteria, and 4 out of 5 subjects in the
epinephrine group and all 5 subjects in the lipid group
reached their recovery criteria. If the criterion from
Mayr et al. had been used, only 3 of the 5 subjects in the
epinephrine group and only 2 of the 5 subjects in the lipid
group would have achieved recovery (16). However, the
study by Weinberg et al. shows that systolic pressure is not
a significant and sufficient criterion for recovery in the
setting of resuscitation for local anesthesia toxicity.
Timing of experiments, route of anesthesia,
measurements on long-term survival, neurologic
improvement, and other organ injury may change the
results of this study.
In conclusion, we observed that adding a lipid
emulsion to epinephrine improved hemodynamic
outcomes and increased survival rates, but resulted in
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similar metabolic parameters. These results are not strong
enough to translate into a clinical setting, but our findings

will support the management of experimental studies and
human trials using lipid infusion.
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